Landscapes / Targets
cytomegalovirus
6 drugs act on cytomegalovirus, in 6 active trials · Any stage · updated 19 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs6
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Cytomegalovirus pUL97 kinase inhibitor |
Phase 3 | 18 Jan 2027Phase 3 trial completes | |||
| How it works | Blocks a kinase | ||||
| Next date | 18 Jan 2027 · Phase 3 trial completes | ||||
| Open drug page | |||||
— |
Moderna · Public MRNA |
Phase 2 | 6 Mar 2027Phase 2 trial completes | ||
| Next date | 6 Mar 2027 · Phase 2 trial completes | ||||
| Open drug page | |||||
— |
Phase 1/2 | 4 Jun 2027Phase 1/2 trial completes | |||
| Next date | 4 Jun 2027 · Phase 1/2 trial completes | ||||
| Also tested for | BKV Infection, EBV Infection | ||||
| Open drug page | |||||
— |
Phase 2 | 31 May 2028Phase 2 trial completes | |||
| Next date | 31 May 2028 · Phase 2 trial completes | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Dec 2028Phase 1/2 trial completes | |||
| Next date | 31 Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Sanfilippo Syndrome (MPS III) | ||||
| Open drug page | |||||
Cytomegalovirus DNA terminase complex inhibitor |
Merck & Co. · Public MRK |
Phase 1 | 14 Apr 2028Phase 1 trial completes | ||
| Next date | 14 Apr 2028 · Phase 1 trial completes | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Covers
- 3 of 3 active trials the registry tags as Cytomegalovirus Infections (100%) · Breakdown
- Checked
- 6 of 6 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026